Blocking 15-PGDH Prevents Brain Barrier Damage, Offers Protection Against Alzheimer’s and Injury in Mice

swift Summary

• A study published in the proceedings of the National Academy of Sciences, Volume 122, Issue 21 (May 2025), investigates key factors related to AlzheimerS disease (AD), traumatic brain injury (TBI), and aging.
• Researchers Koh et al. identified that the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is pathologically elevated in both humans and mice experiencing these conditions.
• the study highlights that this elevation is specifically localized to myeloid cells within the blood-brain barrier.

Read More

Indian Opinion Analysis
The findings from this research shed light on an critically important biological mechanism linked to degenerative neurological conditions such as Alzheimer’s disease and traumatic brain injuries, which are increasingly significant public health challenges globally, including in India where aging populations are growing rapidly. Identifying specific enzymes like 15-PGDH opens pathways for possible therapeutic interventions that could benefit millions struggling with neurodegenerative disorders.

For India, prioritizing scientific collaboration and funding similar research could serve long-term benefits by improving healthcare outcomes while addressing a growing elderly demographic at risk of age-related illnesses such as AD.this revelation underscores the importance of investing in basic research that seeks solutions for complex health issues impacting quality of life worldwide-including advancements beneficial for Indian society’s future healthcare needs.